{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:42:28Z","timestamp":1773722548165,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014489","name":"Johnson and Johnson Pharmaceutical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1097\/01.chi.0000145805.24274.09","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T04:02:51Z","timestamp":1103169771000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Risperidone in Children With Disruptive Behavior Disorders and Subaverage Intelligence: A 1-Year, Open-Label Study of 504 Patients"],"prefix":"10.1016","volume":"44","author":[{"given":"JAN","family":"CROONENBERGHS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOERG M","family":"FEGERT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROBERT L","family":"FINDLING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GOEDELE","family":"DE SMEDT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEFAN","family":"VAN DONGEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/01.chi.0000145805.24274.09_bib1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","article-title":"Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence","volume":"159","author":"Aman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib2","first-page":"485","article-title":"The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0891-4222(95)00039-9","article-title":"The Nisonger CBRF: a child behavior rating form for children with developmental disabilities","volume":"17","author":"Aman","year":"1996","journal-title":"Res Dev Disabil"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib5","first-page":"1427","article-title":"Electroencephalogram and treatment of hospitalized aggressive children with haloperidol or lithium","volume":"18","author":"Bennett","year":"1983","journal-title":"Biol Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4088\/JCP.v62n0405","article-title":"A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities","volume":"62","author":"Buitelaar","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib7","first-page":"374","article-title":"Mental retardation and psychiatric disorders","volume":"42","author":"Campbell","year":"1991","journal-title":"Hosp Community Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/archpsyc.1984.01790180020002","article-title":"Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder","volume":"41","author":"Campbell","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib9","first-page":"233","article-title":"The extrapyramidal symptom rating scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Can J Neurol Sci"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib10","series-title":"CVLT-C: California Verbal Learning Test - Children's Version","author":"Delis","year":"1994"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1176\/appi.ajp.161.5.918","article-title":"Growth and sexual maturation in children are unaffected by long-term treatment with risperidone","volume":"161","author":"Dunbar","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib12","first-page":"16","article-title":"Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia","volume":"53","author":"Fideleff","year":"2000","journal-title":"Horm Res"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1176\/appi.ajp.161.4.677","article-title":"Long-term open-label study of risperidone in children with severe disruptive behaviors and below-average IQ","volume":"161","author":"Findling","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4088\/JCP.v64n1113","article-title":"Prolactin levels during long-term risperidone treatment in children and adolescents","volume":"64","author":"Findling","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00004583-200004000-00021","article-title":"A double-blind pilot study of risperidone in the treatment of conduct disorder","volume":"39","author":"Findling","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib16","series-title":"Manual for the Stony Brook Child Symptom Inventories. Child Symptom Inventory: Parent Checklist. Child Symptom Inventory: Teacher Checklist","author":"Gadow","year":"1994"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib17","first-page":"825","article-title":"Gynecomastia","volume":"23","author":"Glass","year":"1994","journal-title":"Clin Androl"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib18","first-page":"20","article-title":"Molindone hydrochloride treatment of hospitalized children with conduct disorder","volume":"46","author":"Greenhill","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib19","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised 1976","first-page":"217","article-title":"Clinical global impressions","author":"Guy","year":"1976"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ajcn\/32.3.607","article-title":"Physical growth: National Center for Health Statistics percentiles","volume":"32","author":"Hammill","year":"1979","journal-title":"Am J Clin Nutr"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1056-4993(18)30506-6","article-title":"Long-term outcome of disruptive disorders","volume":"3","author":"Hechtman","year":"1994","journal-title":"Child Adolesc Psychiatry Clin N Am"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0015-0282(16)48672-3","article-title":"Further evidence that big, big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian function","volume":"44","author":"Larrea","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib23","series-title":"Nonparametrics: Statistical Methods Based on Ranks, Revised","author":"Lehmann","year":"1998"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jcem.86.6.7521","article-title":"Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method","volume":"86","author":"Leslie","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(98)07059-7","article-title":"Psychopharmacotherapy in children and adults with intellectual disability","volume":"354","author":"Santosh","year":"1999","journal-title":"Lancet"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib26","first-page":"129","article-title":"Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives","volume":"57","author":"Silva","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib28","series-title":"Vineland Adaptive Behavior Scale","author":"Sparrow","year":"1984"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jpepsy\/10.2.215","article-title":"Diagnostic uses of the Vineland Adaptive Behavior Scales","volume":"10","author":"Sparrow","year":"1985","journal-title":"J Pediatr Psychol"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib30","series-title":"A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary","author":"Spreen","year":"1998"},{"issue":"suppl 4","key":"10.1097\/01.chi.0000145805.24274.09_bib31","first-page":"26","article-title":"Neuroreceptor mechanisms of aggression and its treatment","volume":"64","author":"Swann","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch Dis Child"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0891-4222(95)00037-2","article-title":"The Nisonger CBRF: age and gender effect and norms","volume":"17","author":"Tasse","year":"1996","journal-title":"Res Dev Disabil"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib34","series-title":"Stanford-Binet Intelligence Scales","author":"Thorndike","year":"1986"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib35","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1542\/peds.110.3.e34","article-title":"Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs","volume":"110","author":"Turgay","year":"2002","journal-title":"Pediatrics"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/104454601750143348","article-title":"Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial","volume":"11","author":"Van Bellinghen","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0447.1993.tb03350.x","article-title":"Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study","volume":"87","author":"Vanden Borre","year":"1993","journal-title":"Acta Psychiatr Scand"},{"key":"10.1097\/01.chi.0000145805.24274.09_bib38","series-title":"Wechsler Intelligence Scale for Children-Revised","author":"Wechsler","year":"1974"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709613435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709613435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:18:34Z","timestamp":1760192314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709613435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0890856709613435"],"URL":"https:\/\/doi.org\/10.1097\/01.chi.0000145805.24274.09","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risperidone in Children With Disruptive Behavior Disorders and Subaverage Intelligence: A 1-Year, Open-Label Study of 504 Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/01.chi.0000145805.24274.09","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}